Back to search
Generated on www.datasnoop.be
Washingtonstraat, 80, 1050 ElseneNACE 21201 — Vervaardiging van geneesmiddelen
Key FinancialsFY2024
Revenue
€39.1M
↓ 3.4%
EBITDA
€4.1M
↑ 7.5%
Margin
10.5%
Employees
100
↑ 1.6%
Leverage
-0.6x
Net Debt / EBITDA
Equity Ratio
23.8%
Equity / Assets
Int. Coverage
5.7x
EBITDA / Int. Exp
DSO
58d
Days to collect
DPO
31d
Days to pay
Financial History Summary
| Year | Revenue | EBITDA | Margin | Net Profit | FTE |
|---|---|---|---|---|---|
| 2024 | €39.1M -€1.4M ▼ -3.4% | €4.1M +€284K ▲ +7.5% | 10.5% | €2.0M +€31K ▲ +1.6% | 100 +€2 ▲ +1.6% |
| 2023 | €40.4M +€7.0M ▲ +20.8% | €3.8M +€3.4M ▲ +745.4% | 9.4% | €1.9M +€3.1M ▲ +274.5% | 98 +€5 ▲ +5.1% |
| 2022 | €33.5M | €450K | 1.3% | -€1.1M | 94 |
Key People
No administrator data
Recent Publications
No publications yet
Key Shareholders
No shareholder data
Key Subsidiaries
No subsidiary data